NATIONAL BANK OF CANADA /FI/ - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 86 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$383
-57.9%
1,2800.0%0.00%
Q2 2023$909
-20.7%
1,2800.0%0.00%
Q1 2023$1,147
-23.4%
1,2800.0%0.00%
Q4 2022$1,498
-85.0%
1,2800.0%0.00%
Q3 2022$10,000
+400.0%
1,280
+435.6%
0.00%
Q2 2022$2,0000.0%2390.0%0.00%
Q1 2022$2,000
+100.0%
2390.0%0.00%
Q4 2021$1,0002390.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders